Live Breaking News & Updates on Sun yat sen university cancer centre

Coherus BioSciences (CHRS) and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02

Coherus BioSciences (CHRS) and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , United-states , American , Ruihua-xu , Rosh-dias , Jianjun-zou , Junshi-biosciences , Robert-ferris , Endocrinopathiesadrenal-insufficiency , Journal-of-the-american-medical-association , American-society-of-clinical-oncologists , Administration-in-prescribing-information

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with LOQTORZI plus chemotherapy significantly prolongs survival in patients with recurrent or metastatic NPC.

Guangzhou , Guangdong , China , California , United-states , Shanghai , Maryland , Beijing , Suzhou , Jiangsu , American , Chinese

China's world-leading cancer drug makes historic foray into the US amid medicine crisis

World-leading cancer treatment becomes first Chinese biopharmaceutical drug to be approved by America’s FDA.

China , United-states , Qilu , Gansu , Washington , White-house , District-of-columbia , Chinese , Joe-biden , Coherus-biosciences , Xu-ruihua , Junshi-biosciences

Junshi Biosciences and Coherus Announce Results from Phase

Junshi Biosciences and Coherus Announce Results from Phase
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , Taiwan , Shanghai , United-states , Singapore , Suzhou , Jiangsu , Beijing , Maryland , Canada

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Taiwan , United-states , Shanghai , Canada , Singapore , Patricia-keegan , Junshi-bioscience , Ruihua-xu , Mcdavid-stilwell , Junshi-biosciences , Coherus-biosciences

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , Taiwan , Shanghai , United-states , Singapore , Suzhou , Jiangsu , Beijing , Maryland , Canada

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine | Comunicados | Edición USA

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , Taiwan , Shanghai , United-states , Singapore , Suzhou , Jiangsu , Beijing , Maryland , Canada

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , Taiwan , Shanghai , United-states , Singapore , Suzhou , Jiangsu , Beijing , Maryland , Canada

Lobaplatin 'Promising' in Nasopharyngeal Cancer

Lobaplatin 'Promising' in Nasopharyngeal Cancer
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

China , Guangzhou , Guangdong , Italy , United-states , Jilin , Lisa-licitra , Stefano-cavalieri , International-cooperation-project-of-science , Sun-yat-sen-university-cancer-centre , National-science , Astrazeneca

Sound Biologics Announces Proof-of-Concept Success at AACR Annual Meeting

Share this article
Share this article
BOTHELL, Wash., April 13, 2021 /PRNewswire/ Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company focused on developing a novel MabPair
™ platform for antibody-based combination therapies for the treatment of cancer, inflammation and autoimmune disease, announced a clinical update on its first MabPair product PSB205 at the American Association for Cancer Research (AACR) Annual Meeting. Dr Li Zhang of Sun Yat-Sen University Cancer Centre (SYSUCC), Guangzhou, China presented a poster on Phase 1 Clinical Trial results of PSB205, a combination of anti-PD1 and anti-CTLA-4 antibodies that are manufactured together as a single product, in patients with advanced malignant tumors. The study is sponsored by Qilu Pharma in China.

China , Guangzhou , Guangdong , Li-zhang , Zhejiang , United-states , American , Qilu-pharma , Wei-yan , Jelle-kijlstra , American-association-for-cancer-research , Linkedin